Glenmark Pharmaceuticals informs about media release

12 Mar 2025 Evaluate
Glenmark Pharmaceuticals has informed that it attached media release titled ‘Glenmark Pharma Expands Cardiometabolic Portfolio with the Launch of Empagliflozin and its Fixed-Drug Combinations in India’.

The above information is a part of company’s filings submitted to BSE.

Glenmark Pharma Share Price

1956.40 3.50 (0.18%)
11-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1806.90
Dr. Reddys Lab 1272.95
Cipla 1512.10
Zydus Lifesciences 922.45
Lupin 2080.35
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×